We will continue to do that. There is a great deal of upside potential in leaving the company as is.

Even if these improvements fall short of expectations, they will make the company more attractive to a potential buyer.

Locating our headquarters close to our businesses in the Midwest will significantly enhance the lines of communications within the company and increase the overall effectiveness of our operations.

The long term picture and the potential for the company to be acquired is probably more relevant to the share price at this point.

No company has seriously looked at the SMB market, which has a huge potential.

However, the number of potential acquirers could be limited and would likely involve a European drug company.